Literature DB >> 6451650

The differentiation of cytotoxic T cells in vitro. IV. Interleukin-2 production in primary mixed lymphocyte cultures involves cooperation between Qa-1+ and Qa-1- "helper" T cells.

M Okada, T H Stanton, R C Kuppers, C S Henney.   

Abstract

Studies with C57BL/6-TIaa mice have established that both Qa-1+ and Qa-1- helper T cells are required for the optimal production of Interleukin 2(IL-2) activity in primary MLC. This was established both by depletion of Qa-1 bearing cells by treatment of responder cells with anti-Qa-1 serum in the presence of complement and by positive selection (using FACS II analysis) of those cells displaying Qa-1. Furthermore, microfluoremetry revealed that the great majority of C57BL/6-TIaa and of A/J splenic T cells bore Qa-1 alloantigen but that only those with the highest antigen density were susceptible to complement-mediated lysis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6451650

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Structure and expression of glycoproteins controlled by the Qa-1a allele.

Authors:  E Rothenberg; D Triglia
Journal:  Immunogenetics       Date:  1981-12       Impact factor: 2.846

2.  Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules.

Authors:  M Okada; N Yoshimura; T Kaieda; Y Yamamura; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

3.  Two Ly-2 T helper cell subsets distinguished by Qa-1 phenotype. The priming environment determines whether one or both subsets will be generated.

Authors:  J S McDougal; F W Shen; S P Cort; J Bard
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

4.  T-T cell interactions during in vitro cytotoxic T lymphocyte responses. V. Precursor frequencies and specificity of alloreactive helper T cells.

Authors:  M Krönke; P Scheurich; K Pfizenmaier; M Röllinghoff; H Wagner
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.